| | | | | |
ARCL ARC Group Acquisition I Corp Class A Ordinary Shares | $9,9200 | +0,20 % | $177,53M | $206,00 | |
BRR ProCap Financial, Inc. Common Stock | $1,7750 | -4,57 % | $177,46M | $309,74K | |
HUMA Humacyte, Inc. Common Stock | $0,62780 | -1,69 % | $176,93M | $2,56M | |
HTLM HomesToLife Ltd Ordinary Shares | $1,9200 | +4,92 % | $176,68M | $1,58K | |
| $54,4000 | +1,74 % | $176,47M | $57,24K | |
FLC Flaherty & Crumrine Total Return Fund Incorporated | $16,6400 | -0,60 % | $176,30M | $19,89K | |
PAAC Proem Acquisition Corp I Ordinary Shares | $9,9510 | -0,09 % | $176,16M | $126,00 | |
BNR Burning Rock Biotech Limited American Depositary Shares | $9,2500 | +3,35 % | $176,12M | $1,95K | |
LFCR Lifecore Biomedical, Inc. Common Stock | $4,3300 | -2,26 % | $175,91M | $106,83K | |
CHEC Chenghe Acquisition III Co. Class A Ordinary Share | $10,1450 | -0,44 % | $175,51M | $10,00K | |
| $3,8500 | +2,12 % | $175,38M | $94,40K | |
ECBK ECB Bancorp, Inc. Common Stock | $19,9100 | -1,58 % | $175,16M | $7,48K | |
TNXP Tonix Pharmaceuticals Holding Corp. | $9,8850 | -6,92 % | $175,02M | $715,11K | |
| $9,0800 | +0,67 % | $174,89M | $180,34K | |
DHF BNY Mellon High Yield Strategies Fund | $2,3500 | -0,42 % | $174,56M | $589,13K | |
